Cytogen cuts staff at AxCell unit

Radiopharmaceutical firm Cytogen has cut staff at its AxCell Biosciences unit by 75% in what the company said was a sign of its continuing emphasis on oncology products. The move is expected to lower Cytogen’s annual operating expenses by about $1.4 million, starting in the fourth quarter of 2002.

By AuntMinnie.com staff writers
September 17, 2002

Related Reading

Cytogen warned by Nasdaq, August 15, 2002

Cytogen revenues climb in Q2, August 1, 2002

ProstaScint being tested as IMRT guide, June 6, 2002

Cytogen raises $5 million, June 5, 2002

Cytogen brings BrachySeed Pd-103 to U.S., May 30, 2002

Copyright © 2002 AuntMinnie.com

Page 1 of 3617
Next Page